Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 762-764, 2004; 10.1373/clinchem.2003.025585
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, G. R.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, G. R.D.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2004;50:762-764.)
© 2004 American Association for Clinical Chemistry, Inc.

Technical Briefs

Reevaluation of the Power of Error Detection of Westgard Multirules

Graham R.D. Jones1

1 Department of Chemical Pathology, St. Vincent’s Hospital, Darlinghurst, NSW, 2010, Australia; fax 61-2-8382-2489, e-mail gjones@stvincents.com.au

The first 300 words of the full text of this article appear below.

The multirules system for optimizing assay error detection originally developed by James Westgard and others is now widely used in clinical pathology laboratories (1). The power of various combinations of rules to detect changes in assay performance can be assessed by use of power function charts (2), some of which are freely available on the Westgard QC website (3). In this report I reassess the power of error detection of rules that require data from more than one quality-control (QC) run.

Variables that can be adjusted in setting a QC protocol, and modeled in power function charts, include the choice of rules, the number of QC samples in a run (n), and the number of runs over which data are to be assessed (R). In the development of power function charts, other variables must also be clearly defined so that the charts represent the actual practice in the laboratory.

Westgard’s rules can be divided into within-run rules, where the data for decision-making are available from within one QC run, and cross-run rules, where data from more than one QC run are required (R >1). Using approved terminology (4), examples of within-run rules for n = 2 include 13s and 22s, and examples of cross-run rules for n = 2 include 41s and 10x. Within-run QC rules are clearly preferable to cross-run rules because they will allow detection of changes in assay performance as soon as possible after the change. Cross-run rules are commonly added to within-run rules with the aim of gaining additional power of error detection to meet quality specifications.

In this report I use a spreadsheet application to develop power function charts with the aim of assessing the power of error detection of combinations of rules when cross-run rules . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.